ezetimibe
NDC 82009-024, ezetimibe, tablet, from Quallent Pharmaceuticals Health LLC.
- Product NDC
- 82009-024
- Status
- Listed
- Labeler
- Quallent Pharmaceuticals Health LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204331
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82009-024 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EZETIMIBE10 mg/1
Pharmacologic classes
Decreased Cholesterol Absorption [PE]; Dietary Cholesterol Absorption Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82009-024-05 | 82009002405 | 500 TABLET in 1 BOTTLE (82009-024-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/68247ce8-e812-42f2-a3ba-0f6e49acca63NADAC price for package 82009002405
GET /v1/drugs/nadac/82009002405
Use it
Look up 82009-024 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82009-024 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82009-024. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.